
|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Political Science
Concern that gene and stem-cell research could lead to human cloning has generated proposals for legislative bans, which could block promising research.
Advertisement
Articles in this issue
almost 25 years ago
Policy: Task Mastersalmost 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearalmost 25 years ago
Friends of Complexityalmost 25 years ago
Under Federal Firealmost 25 years ago
Task Force: Enter the Fixersalmost 25 years ago
The Next Y2KNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5




